SCHEMBL8320871

SCHEMBL8320871

O=C(COc1ccccc1)N1CCOCC1

nearest known ligand 0.79

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.79
MEN1 O00255 1/20 0.78
KMT2A Q03164 1/20 0.78
FKBP1A P62942 9/20 0.73
POLB P06746 1/20 0.73
USP2 O75604 2/20 0.68
HPGD P15428 2/20 0.68
GAA P10253 1/20 0.66
ACHE P22303 1/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
KDM4E B2RXH2 1/20 0.64
LMNA P02545 1/20 0.64
HTT P42858 1/20 0.64
ME2 P23368 1/20 0.63
ME1 P48163 1/20 0.63
ME3 Q16798 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10721826 0.88 MEN1 (1.00) ALDH1A1MEN1KMT2APOLBUSP2
SCHEMBL29516320 0.85 MEN1 (0.86) ALDH1A1MEN1KMT2APOLBUSP2
SCHEMBL2712996 0.84 FKBP1A (0.74) ALDH1A1MEN1KMT2AFKBP1APOLB
SCHEMBL15919449 0.84 FKBP1A (0.74) ALDH1A1MEN1KMT2AFKBP1APOLB
SCHEMBL3154984 0.84 FKBP1A (0.69) ALDH1A1MEN1KMT2AFKBP1APOLB
SCHEMBL13534672 0.84 FKBP1A (0.92) ALDH1A1FKBP1APOLBUSP2HPGD
SCHEMBL9041797 0.84 ALDH1A1 (0.74) ALDH1A1MEN1KMT2AFKBP1APOLB
SCHEMBL3373792 0.84 FKBP1A (0.73) ALDH1A1KMT2AFKBP1APOLBUSP2
SCHEMBL3096037 0.84 FKBP1A (0.74) ALDH1A1MEN1KMT2AFKBP1APOLB
SCHEMBL10064244 0.83 MEN1 (0.83) ALDH1A1MEN1KMT2APOLBUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2870156-B1 PYRIMIDINONE DERIVATIVES AS ANTIMALARIAL AGENTS SANOFI SA (FR) 2020-06-17 EP disclosed
US-9321790-B2 Pyrimidinone derivatives as antimalarial agents SANOFI (FR) 2016-04-26 US disclosed
US-9321790-B2 Pyrimidinone derivatives as antimalarial agents SANOFI (FR) 2016-04-26 US disclosed
US-20150183804-A1 Pyrimidinone Derivatives as Antimalarial Agents SANOFI (FR) 2015-07-02 US disclosed
US-20150183804-A1 Pyrimidinone Derivatives as Antimalarial Agents SANOFI (FR) 2015-07-02 US disclosed
US-7183409-B2 Basic mono- and bisazo compounds CLARIANT FINANCE (BVI) LIMITED (VG) 2007-02-27 US disclosed
US-7183409-B2 Basic mono- and bisazo compounds CLARIANT FINANCE (BVI) LIMITED (VG) 2007-02-27 US disclosed
EP-0633259-B1 Sulfonylaminopyrimidines, their preparation and their use as medicine HOFFMANN LA ROCHE (CH) 1999-01-13 EP disclosed
US-5541186-A ENDOTHELIN RECEPTOR INHIBITORS HOFFMANN-LA ROCHE INC. (US) 1996-07-30 US disclosed
EP-0633259-A1 Sulfonylaminopyrimidines, their preparation and their use as medicine F. HOFFMANN-LA ROCHE AG (CH) 1995-01-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150183804-A1 Pyrimidinone Derivatives as Antimalarial Agents DHFR, PRMT1, PRMT7 ALDH1A1 1237/4885MEN1 633/4885KMT2A 477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.